Ultimate magazine theme for WordPress.

- реклама -

iNCOVACC (BBV154) | India’s first intranasal Covid -19 vaccine | Bharat Biotech | #shorts

0

India’s first intranasal Covid vaccine — iNCOVACC (BBV154) by Bharat Biotech received DCGI approval on Tuesday for primary immunization against the infection for people above the age of 18.

@Ministry of Health & Family Welfare

#covid19 #indiavaccination

Оставьте ответ

Ваш электронный адрес не будет опубликован.